Embed
Email

Genetic Testing Market and Forecast - Global Analysis 2010 – 2015

Document Sample
Genetic Testing Market and Forecast - Global Analysis 2010 – 2015
Description

Report Details

“Genetic Testing Market & Future Forecast - Global Analysis 2010 – 2015” report published by Renub Research provides an in-depth analysis of the past, present and future prospects. The report has been researched at source globally and features latest available data covering:

• Global Genetic Testing Market (2005 – 2015)
• Top 5 application wise genetic testing (Cancer Genetic Testing, Prenatal Genetic Testing, Predisposition Genetic Testing, Pharmacogenomics Genetic Testing) data of Past, Present and Future Market
• United States immigration genetic testing market
• Top Corporate past, present developments
• Top Laboratory Merger & Acquisition deals from 2007 - 2009
• Driving forces for the growth of global genetic testing market
• Challenges faced by genetic testing market in the coming years
• Key Players analysis in the genetic testing market

Research Highlights

• Globally, Genetic Testing market is expected to cross the figure of US$ 10 Billion by 2015
• Cancer Genetic testing dominates the Genetic Testing market with more than 35% market share by 2015
• Cancer Genetic Testing and Pharmacogenomics testing are likely growth leaders in the genetic testing market.
• Prenatal & Predisposition genetic testing will have a combined market share of 26% by 2015

Company Analysis

This section covers the key facts about the major companies that play an important role in Genetic Testing Market. The companies analyzed in this section are – Orchid Cellmark Inc, 23andMe, Pathway Genomics Corporation, Navigenics, Decode Genetic. All the companies have been analyzed from two points of view 1) Strength of the company in genetic testing market 2) Weakness of the company in genetic testing market.

Data Sources

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Renub Research team of industry experts.

Information and data has been collect

Renub Research

www.renub.com



Genetic Testing Market and Forecast - Global

Analysis 2010 – 2015









Publisher: Renub Research

Published: November, 2011

Genetic Testing - Market Overview



The genetic testing market is witnessing a period of profound growth. Growing with a CAGR of

18 percent globally genetic testing market is expected to cross the figure of US$ 10 Billion by

2015. This significant growth is primarily attributed to the incidence of genetic diseases,

burgeoning demand for molecular diagnostics, aging population, and subsequent increase in

chronic diseases. Increasing knowledge about the potential benefits in genetic testing has

been one of the prime reasons for the growth in genetic testing.





Pharmacogenomics is the most lucrative segment of genetic testing. Cancer genetic testing

should post strong position in the genetic testing industry due to rising cases of cancer

patients with the market share of around 23% in 2010 and it is expected that cancer genetic

testing will lead the genetic testing market by 2015. The future growth in genetic testing is

expected to come from prenatal and predisposition genetic testing.





Genetic testing is becoming an integral and growing part of healthcare provision and services.

Advancements in genetic testing, together with genetically engineered drugs, are expected to

aid in tailoring personalized medicine for specific races, individuals, and families. The genetic

testing sector will grow rapidly over the next 5 to 10 years and spread beyond the small

number of specialist genetic centres.









Report Details



“Genetic Testing Market & Future Forecast - Global Analysis 2010 – 2015” report published

by Renub Research provides an in-depth analysis of the past, present and future prospects.

The report has been researched at source globally and features latest available data covering:





 Global Genetic Testing Market (2005 – 2015)

 Top 5 application wise genetic testing (Cancer Genetic Testing, Prenatal Genetic

Testing, Predisposition Genetic Testing, Pharmacogenomics Genetic Testing) data of

Past, Present and Future Market

 United States immigration genetic testing market

 Top Corporate past, present developments

 Top Laboratory Merger & Acquisition deals from 2007 - 2009

 Driving forces for the growth of global genetic testing market

 Challenges faced by genetic testing market in the coming years

 Key Players analysis in the genetic testing market





Research Highlights



 Globally, Genetic Testing market is expected to cross the figure of US$ 10 Billion by

2015

 Cancer Genetic testing dominates the Genetic Testing market with more than 35%

market share by 2015

 Cancer Genetic Testing and Pharmacogenomics testing are likely growth leaders in the

genetic testing market.

 Prenatal & Predisposition genetic testing will have a combined market share of 26% by

2015





Company Analysis



This section covers the key facts about the major companies that play an important role in

Genetic Testing Market. The companies analyzed in this section are – Orchid Cellmark Inc,

23andMe, Pathway Genomics Corporation, Navigenics, Decode Genetic. All the companies

have been analyzed from two points of view 1) Strength of the company in genetic testing

market 2) Weakness of the company in genetic testing market.





Data Sources



This report is built using data and information sourced from proprietary databases, primary

and secondary research and in-house analysis by Renub Research team of industry experts.





Information and data has been collected from various printable and non-printable sources like

search engines, News websites, Government Websites, Trade Journals, White papers,







© Renub Research Page 3 of 16

Government Agencies, Magazines, Newspapers, Trade associations, Books, Industry Portals,

Industry Associations and access to more than 100 paid databases.









© Renub Research Page 4 of 16

About Us



Renub Research is a leading Market Research and Information Analysis Company with

centers at Noida India and Roswell USA. We have long-term experience especially in

international Business-to-Business Researches, Surveys, Business and Consulting. Throughout

the years we have acquired expertise in most market sectors, including Information

Technology (IT), Telecoms, Life Sciences, Medical & Pharmaceuticals, Financial Services

(Banking, Insurance, Reinsurance, M&A, etc.), Energy, Chemicals, Automotive, Retail, FMCG,

Consumer Goods, Logistics, Governmental, Social, and Others.





Our core team is comprised of an experienced people holding graduate, post graduate and

Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information

Technology, Environmental Science and many more. Our research help make the business

decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We

support many blue chip companies by providing them findings and perspectives across a wide

range of markets. Our research reports offer a blend of information insight, analysis and

forecasting that is essential in today’s ultra-competitive markets.









For more information on us or to view any of our sample work you can

mail us at info@renub.com









© Renub Research Page 5 of 16

Published

By



Renub Research

A–116B, Sector–27

Noida – 201301

Phone: +91-120-421-9822, 254-5750 (India)

+1-678-302-0700 (USA)

Fax : +91-120-424-9780

Email: info@renub.com

www.renub.com









© Genetic Testing Market and Forecast - Global Analysis 2010 – 2015

Renub Research, 2011

Edition 1.0

All rights reserved. This publication is protected

by copyright. No part of it may be reproduced, stored

in a retrieval system or transmitted, in any form or by

any means, electronic mechanical, photocopying,

recording or otherwise without the prior written

permission of the publishers









© Renub Research Page 6 of 16

Table of Contents



1. Executive Summary



2. Global Genetic Testing Market



3. Genetic Testing Market Share & Future Forecast



4. Genetic Testing Market (Application Segment) 2005 – 2015



4.1 Cancer Genetic Testing Market



4.2 Prenatal Genetic Testing Market



4.3 Predisposition Genetic Testing Market



4.4 Pharmacogenomics Genetic Testing Market



5. Corporate Developments



5.1 LabCorp to Buy Genzyme's Genetic Testing Unit



5.2 DNA Testing Systems Inks Agreement with DNAPrint Genomics Inc



5.3 Hologic to Acquire Third Wave Technologies



5.4 PerkinElmer Acquires Newborn Metabolic Screening Assets of Pediatrix



5.5 Affymetrix to Acquire Panomics



6. Laboratory Merger & Acquisition



7. Driving Forces for Genetic Testing



7.1 Present Development and Future of Genetic Testing Market



7.2 Increased Incidence of Cancer



7.3 Emerging Economies is Expected to Drive the Market in Future



7.4 Increasing Availability of Tests Allows More Patients to be Diagnosed



7.5 Availability of Direct-to-Consumer Tests to Increase Test Volumes



8. Challenges for Genetic Testing



8.1 Lack of a Coherent Oversight System to Ensure the Quality of Tests and Testing Laboratories ..



8.2 Dearth of Professional Guidelines for Conducting Genetic Tests



9. Companies Analysis



9.1 Orchid Cellmark Inc







© Renub Research Page 7 of 16

9.1.1 Strengths

9.1.2 Weaknesses



9.2 23andMe

9.2.1 Strengths

9.2.2 Weaknesses



9.3 Pathway Genomics Corporation

9.3.1 Strengths

9.3.2 Weaknesses



9.4 Navigenics

9.4.1 Strengths

9.4.2 Weaknesses



9.5 deCODE Genetics

9.5.1 Strengths

9.5.2 Weaknesses









© Renub Research Page 8 of 16

List of Figures:





Figure 2-1: Global – Genetic Testing Market (Million US$), 2005 – 2010

Figure 2-2: Global – Forecast for Genetic Testing Market (Million US$), 2011 – 2015

Figure 3-1: Global – Genetic Testing Market Share (Percent), 2008 – 2010

Figure 3-2: Global – Forecast for Genetic Testing Market Share (Percent), 2011 – 2015

Figure 4-1: Global – Cancer Genetic Testing Market (Million US$), 2000 – 2010

Figure 4-2: Global – Forecast for Cancer Genetic Testing Market (Million US$), 2011 – 2015

Figure 4-3: Global – Prenatal Genetic Testing Market (Million US$), 2000 – 2010

Figure 4-4: Global – Forecast for Prenatal Genetic Testing Market (Million US$), 2011 – 2015

Figure 4-5: Global – Predisposition Genetic Testing Market (Million US$), 2000 – 2010

Figure 4-6: Global – Forecast for Predisposition Genetic Testing Market (Million US$), 2011 – 2015

Figure 4-7: Global – Pharmacogenomics Genetic Testing Market (Million US$), 2005 – 2010

Figure 4-8: Global – Forecast for Pharmacogenomics Genetic Testing Market (Million US$), 2011 – 2015

Figure 5-1: United States – Immigration Testing Market (Million US$), 2007 – 2010

Figure 5-2: United States – Forecast for Immigration Testing Market (Million US$), 2011 – 2015

Figure 8-1: BRIC – In Vitro Diagnostic Market (Billion US$), 2009 – 2010

Figure 8-2: BRIC – Forecast for In Vitro Diagnostic Market (Billion US$), 2011 – 2015

Figure 8-3: Global – Growth of Laboratory Directory (Number), 2000 – 2010

Figure 8-5: Global – Direct to Consumer Genetic Testing Market (Million US$), 2008 – 2010

Figure 8-6: Global – Forecast for Direct to Consumer Genetic Testing Market (Million US$), 2011 – 2015

Figure 10-1: Orchid Cellmark Inc Laboratories – Key Financials (Million US$) 2007 – 2009









© Renub Research Page 9 of 16

List of Tables:





Table 6-1: LabCorp & Genzyme Genetic – Acquisitions (Million US$), 2010

Table 6-2: Hologic & Third Wave Technologies – Acquisitions (Million US$), 2008

Table 6-3: PerkinElmer Inc & Pediatrix Medical Group – Acquisitions 2008

Table 6-4: Affymetrix & Panomics – Acquisitions (Million US$), 2008

Table 7-1: Global – Laboratory Merger & Acquisition (Million US$), January 2007 – July 2009

Table 8-1: Global – New Cancer Cases & Deaths & Forecast (Million), 2000 & 2020

Table 8-2: Global – All Cancers (excluding non-melanoma Skin Cancer) Incidence and Mortality

(Thousand), 2008









© Renub Research Page 10 of 16

Order Form



Scan and e-mail this page to info@renub.com, alternatively one can also write the Contact

Information in an e-mail and mail it. Else you can also fax this form to +91-120-424-9780





Questions? Please call +91-120-421-9822 (India), +1-678-302-0700 (USA) or mail to

info@renub.com





Format



Report Title: Genetic Testing Market and Forecast - Global Analysis 2010 – 2015





Single User Hard Copy CD – Rom Global Site License

(Email from Publisher) (Mail Delivery) (Mail Delivery) (Multiple User License)

US$ 1,000 US$ 1,100 US$ 1,100 US$ 1,600







For ordering this report: Three easy ways to place your order:



1) Order online by Credit Card (Visa, MasterCard, etc.):

http://renub.com/reports/showdetails.aspx?id=52





2) Order by Wire Transfer:

http://renub.com/reports/wiretransfer.aspx?id=52&pid=1186





To pay by Wire Transfer, please, fill in your contact details in the form below:









© Renub Research Page 11 of 16

Bank Details



Account Name: Renub Research

A/C No.: 109102000023296

Name of Bank: IDBI Bank Ltd.

Swift Code: IBKLINBB010

Bank Address: 4th Floor

Indian Red Cross Building

1 Red Cross Road

Opposite Parliament Street

New Delhi – 110001

India









Contact Information



First Name: Last Name:

Email:

Job Title:

Company:

Address:

City:

Postal/Zip Code:

Country:

Phone:

Mobile:

Fax:

Report Format:

Your message:









© Renub Research Page 12 of 16

3) Order by Check





Please post the check accompanied by this form, to:





Company Address: Renub Research

A -116B

Sector -27

Noida - 201301

Uttar Pradesh

India

Phone: +91-120-421-9822, 424-9780









For free Sample copy report or to view any of our sample work please contact us at

info@renub.com or call +91-120-421-9822 (India), +1-678-302-0700 (USA)









Follow Us





Facebook: http://www.facebook.com/pages/Renub-Research/233380966701090

LinkedIn: http://www.linkedin.com/company/renub-research

Twitter: http://twitter.com/RenubResearch









© Renub Research Page 13 of 16

Related Reports



Global Osteoporosis Market & Drugs Analysis 2010 – 2015





Global Schizophrenia Prevalence, Companies Analysis & Drugs Forecast (2010 – 2015)





Global Molecular Diagnostics Market & Future Forecast 2010 - 2014





Alzheimer’s Disease Patients & Market Worldwide, Future Scenario (2010 – 2015) & Drugs

Analysis





Global Cardiovascular Surgery Devices Market Trends and Future Forecast (2009 - 2014)





Personalized Medicine Market (2010 - 2015) - By Segments, Technologies, Opportunities,

Challenges & Future Forecast





World Vaccines Market: Vaccine Segments Analysis, Vaccine Cases and Future Forecast





Global In Vitro Diagnostics (IVD) Market Trends and Future Forecast (2009 – 2014)





Glucose Monitoring Devices Market Worldwide (2010 – 2014)





Global Diabetes Market Trends & Future Forecast – Diabetes Drug (Anti-Diabetic Drug), Insulin,

DPP-IV, GLP-1





Asia Medical Tourism Analysis (2008 – 2013)





Global Molecular Diagnostics Market: Opportunities & Future Forecast





Insulin Delivery Devices Market Analysis and Future Forecast





World Vaccines Market 2008-2013: Future Forecast, Critical Trends and Developments









© Renub Research Page 14 of 16

Our Partial List of Clients





Redbus Bain



Becton Dickinson WAKE Technology Services, Inc.



Pfizer PSS World Medical



Intercell Relypsa



Sanofi Pasteur C&K components



Stanford Burgess Konkuk University



Pequot Capital Resonetics



DMI Samsung



Transgene S.A. SEKISUI MEDICAL CO. LTD.



ixia communications Plentyoffish Media INC



Toyota Tsusho Amercia Inc. Arthur D Little Gmbh



National Health Research Institutes Morgan Stanley



Abbott Diabetes Care Takeda Pharmaceutical Corporation



Corning Incorporated - Life Sciences Hokkai School of Commerce



L.E.K. Consulting GmbH Ministry of Manpower Singapore



Syntiron GenOmind, LLC.



MediVas LLC Goldman Sachs & Co



Credit Suisse NTT Advanced Technology



Dune Medical Tokyo Womens Medical University



QIAGEN The Chemo-Sero-Therapeutic Research



Inje University Trade Council of Iceland



Mapp Biopharmaceutical Jpmorgan, Ets Trading



Institute for Information Industry GE Healthcare IT



NorDiag ASA ixia communications

© Renub Research Page 15 of 16

Rep e Inv Medicas SA de



Innogenetics

Disclaimer



This research report is published by Renub Research. All rights reserved. Reproduction or

redistribution of this research report in any form for any business purpose is expressly

prohibited without written permission of www.renub.com and any payments of a specified

fee. Requests to republish any material may be sent to us at info@renub.com.





Most of the information available in this report is within the public domain. The submitting

authors or other copyright holders retain rights for reproduction or redistribution. All persons

reproducing or redistributing this information are expected to adhere to the terms and

constraints invoked by the copyright holder. Such protected material, however, may be used

under the terms of "fair use” as defined in the copyright laws, which generally permit use for

non-commercial educational purposes such as teaching, research, criticism, and news

reporting.





With respect to documents available, neither the company nor any of its employees makes

any warranty, express or implied, including the warranties of merchantability and fitness for

a particular purpose, or assumes any legal liability or responsibility for the accuracy,

completeness, or usefulness of any information, apparatus, product, or process disclosed, or

represents that its use would not infringe privately owned rights.









© Renub Research Page 16 of 16


Related docs
Other docs by Ankit Mishra